At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 63 enrolled
Drug / intervention
Autologous UCB Reinfusion +1 morebiological
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Is Autologous Umbilical Cord Blood Reinfusion Beneficial in Children With Cerebral Palsy: A Randomized, Blinded, Placebo-Controlled, Crossover Study
In Brief
A Phase 2 clinical trial evaluating Autologous UCB Reinfusion and Placebo for Cerebral Palsy and 2 related conditions. Completed, enrolled 63 participants across 1 site.
Detailed Summary
The purpose of this study is to determine the efficacy of a single intravenous infusion of autologous umbilical cord blood (UCB) for the treatment of pediatric patients with spastic cerebral palsy.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCerebral Palsy, CP, Spastic Cerebral Palsy
CountriesUnited States
CollaboratorsThe Robertson Foundation
Timeline
Phase 2CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartJun 2010
First PostedJun 2010
Primary CompletionMar 2016
TodayJul 2026
First PostedJun 22, 2010
Enrollment StartJun 1, 2010
Primary CompletionMar 1, 2016
TodayJul 2, 2026
Enrollment to primary: 5.8 yearsPosted 16.0 years ago
Interventions
Autologous UCB Reinfusionbiological
Autologous umbilical cord blood (UCB) reinfusion
Placeboother
Placebo